Olivia Zaegel-Faucher Selected Research

Fibrosis (Cirrhosis)

1/2022

Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivia Zaegel-Faucher Research Topics

Disease

3	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 10/2018
2	Coinfection 01/2022 - 07/2015
2	HIV Infections (HIV Infection) 01/2019 - 06/2018
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022
1	Castleman Disease (Castleman's Disease) 01/2022
1	Progressive Multifocal Leukoencephalopathy 01/2022
1	Multiple Myeloma 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Reinfection 01/2020
1	Osteoporosis 01/2017
1	Frailty 01/2017

Drug/Important Bio-Agent (IBA)

2	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2018
2	Tenofovir (Viread)FDA Link 01/2019 - 01/2017
1	Immunoglobulin A (IgA)IBA 01/2022
1	Viral RNAIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	N-acetoacetyl-N-deacetylcolchicineIBA 01/2021
1	Emtricitabine (Emtriva)FDA Link 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 10/2018
1	Reverse Transcriptase InhibitorsIBA 10/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017

Therapy/Procedure

3	Therapeutics 01/2022 - 07/2015
1	Highly Active Antiretroviral Therapy (HAART) 01/2022
1	Drug Therapy (Chemotherapy) 01/2022